Background: Currently, quadruple therapy is unanimously recommended as the current first-line treatment option for Helicobacter pylori (H. Pylori) eradication. However, the drug composition of quadruple therapy is very complex, and the efficacy and safety between them is not clear.
Aims: To compare the efficacy and safety of H. Pylori eradication regimens, which were recommended by the Fifth Consensus of China, by network meta-analysis.
Methods: Literature databases were used to retrieve clinical randomized controlled trials of H. Pylori eradication. Network meta-analysis was performed using BUGSnet and meta package of R software, using OR values as effect size, and SUCRA was used to rank the efficacy of interventions under each outcome.
Results: A total of 55 studies and 130 arms were included. The NMA analysis found that the top regimen in term of eradication rate outcome was: Rabeprazole + Bismuth + Furazolidone + Tetracycline (SUCRA, 97.5). In terms of safety outcomes: Lansoprazole + Bismuth + Amoxycillin + Clarithromycin (SUCRA, 91.97).
Conclusions: The bismuth quadruple therapies recommended by the guidelines for the treatment of H. Pylori have good performance in terms of four-week eradication rate and safety outcome indicators, and due to the different resistance of antibiotics in different regional populations, rational use of drugs should be combined with local conditions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11841909 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0318937 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Assessing the application of American Heart Association (AHA) guidelines in the management of heart failure with reduced ejection fraction.
Egypt Heart J
March 2025
Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Background: Heart failure (HF) is a significant global health issue. Appropriate and timely treatment at target doses significantly reduces mortality and enhances quality of life. However, studies indicate suboptimal pharmacotherapy among patients.
View Article and Find Full Text PDFUse of Remote Assessment Tools to Substitute Routine Outpatient Care: Scoping Review.
J Med Internet Res
March 2025
School of Medicine, University of Queensland, Brisbane, Australia.
Background: The increasing global demand for health care, driven by demographic shifts, the rise of personalized medicine, and technological innovations necessitate novel approaches to health care delivery. Digital remote assessment tools have emerged as a promising solution, enabling hybrid care models that combine traditional and remote patient management. These tools support the quadruple aim of health care by enhancing the monitoring and evaluation of patient-reported data, thereby improving patient care, boosting operational efficiency, reducing costs, and improving the experience of patients and clinicians.
View Article and Find Full Text PDFUltrasound speckle tracking imaging measurement of endocardial longitudinal strain for evaluation of prognostic value of "new quadruple" therapy in patients with chronic heart failure.
Front Endocrinol (Lausanne)
March 2025
Department of Cardiology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Purpose: This study aimed to evaluate the effectiveness of the "new quadruple" therapy in chronic heart failure (CHF) patients with metabolic syndrome using 2D speckle tracking imaging (2D-STI) stratified strain imaging to measure endocardial longitudinal strain while exploring its underlying neuroendocrine mechanisms.
Patients And Methods: The study retrospectively analyzed 158 patients with heart failure with reduced ejection fraction [HFrEF; left ventricular ejection fraction (LVEF) < 40%] treated with the "new quadruple" therapy (angiotensin receptor neprilysin inhibitor (ARNI), sacubitril/valsartan, dapagliflozin, bisoprolol, and spironolactone) for 8 weeks. Conventional ultrasound indices, left ventricular global longitudinal strain (LVGLS), and subendocardial longitudinal strain (LS) were measured pre- and post-treatment.
[Clinical characteristic analysis of refractory infection of 637 patients].
Zhonghua Nei Ke Za Zhi
March 2025
Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.
To evaluate the effectiveness of empiric eradication therapy recommendations and medication principles for refractory infections based on the 2022 () infection treatment guidelines in China in clinical practice. A retrospective analysis was conducted to evaluate the eradication efficacy of and the safety and treatment compliance among of 637 patients with refractory infection in our center over the past 10 years. Risk factors affecting efficacy of eradication were evaluated.
View Article and Find Full Text PDFVonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized controlled trial.
J Antimicrob Chemother
March 2025
Department of Gastroenterology, Zhejiang Provincial Clinical Research Center for Digestive Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Background: Helicobacter pylori eradication in penicillin-allergic patients presents challenges. Options of effective regimens are lacking in areas where tetracycline is unavailable.
Objectives: To evaluate the efficacy of replacing the proton pump inhibitor (PPI) with a potassium-competitive acid blocker (P-CAB, vonoprazan) in standard bismuth quadruple therapy containing doxycycline and metronidazole as a first-line treatment for H.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!